Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / OCUL - Ocular Therapeutix® to Host Investor Day on June 13 2024 | Benzinga


OCUL - Ocular Therapeutix® to Host Investor Day on June 13 2024 | Benzinga

  • Company to highlight corporate strategy, clinical data, and development plans for AXPAXLI™ in wet AMD and NPDR

    Event to feature prominent retinal disease experts Baruch D. Kuppermann, MD, PhD (University of California, Irvine) and Dilsher S. Dhoot, MD (California Retina Consultants)

    In-person event with virtual access to take place on June 13, 2024, at 2:00 PM ET

    BEDFORD, Mass., June 05, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular", the "Company")), a biopharmaceutical company committed to enhancing people's vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, will host an Investor Day on Thursday, June 13, 2024. The in-person event with virtual access will begin at 2:00 PM ET. To register, click here.

    The Investor Day will feature prominent retinal disease key opinion leaders (KOLs) Baruch D. Kuppermann, MD, PhD (University of California, Irvine) and Dilsher S. Dhoot, MD (California Retina Consultants). The event will include presentations from senior Company leaders providing:

    • An overview of the Company's updated corporate strategy, pipeline priorities, and future development plans;
    • A review of Ocular's clinical program for AXPAXLI in the treatment of wet AMD, including a progress update for the ongoing SOL-1 study; and
    • An update and discussion of the Phase 1 HELIOS data for AXPAXLI in non-proliferative diabetic retinopathy (NPDR).

    Ocular's Investor Day will also include KOL roundtable discussions followed by a live Q&A session. In-person attendees are invited to join Ocular leadership and the participating KOLs for a networking reception to conclude the event.

    A live webcast of the presentation will be available under "Events and ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: Ocular Therapeutix Inc.
    Stock Symbol: OCUL
    Market: NASDAQ
    Website: ocutx.com

    Menu

    OCUL OCUL Quote OCUL Short OCUL News OCUL Articles OCUL Message Board
    Get OCUL Alerts

    News, Short Squeeze, Breakout and More Instantly...